Bjørn-Eivind Kirsebom
Førsteamanuensis II
Stillingsbeskrivelse
Forskning, undervisning og veiledning innen klinisk nevropsykologi/nevrologi med spesielt fokus på demenssykdomer.
Leder Dementia Disease Initiation (DDI) avd. Tromsø.
Luiza Chwiszczuk,
Monica Haraldseid Breitve,
Bjørn-Eivind Kirsebom,
Per Selnes,
John Christian Jøraholmen Fløvig,
Anne Brita Knapskog
m.fl.:
The ANeED study – ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trial
Therese Händel Waggestad,
Bjørn-Eivind Kirsebom,
Carsten Strobel,
Anders Wallin,
Marie Eckerström,
Tormod Fladby
m.fl.:
Improving validity of the trail making test with alphabet support
Jonas Alexander Jarholm,
Atle Bjørnerud,
Turi Olene Dalaker,
Mehdi Sadat Akhavi,
Bjørn-Eivind Kirsebom,
Lene Pålhaugen
m.fl.:
Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort
Journal of Alzheimer's Disease 2023 DOI
Ingrid Myrvoll Lorentzen,
Johan Jacob Espenes,
Ingvild Vøllo Eliassen,
Erik Hessen,
Knut K Waterloo,
Arne Exner Nakling
m.fl.:
Investigating the relationship between allocentric spatial working memory and biomarker status in preclinical and prodromal Alzheimer’s disease
Johan Jacob Espenes,
Ingrid Myrvoll Lorentzen,
Ingvild Vøllo Eliassen,
Erik Hessen,
Knut K Waterloo,
Santiago Timón
m.fl.:
Regression-based normative data for the D-KEFS Color-Word Interference Test in Norwegian adults ages 20–85
Fredrik Öhman,
Marie Eckerström,
Erik Hessen,
Johan Jacob Espenes,
Ingvild Vøllo Eliassen,
Ingrid Myrvoll Lorentzen
m.fl.:
Demographically adjusted Rey–Osterrieth Complex Figure Test norms in a Swedish and Norwegian cohort aged 49–77 years and comparison with North American norms
Scandinavian Journal of Psychology 2023 DOI
Santiago Timón,
Mariano Rincón,
Rafael Martínez-Tomás,
Bjørn-Eivind Seljelid Kirsebom,
Tormod Fladby
:
A Knowledge Graph Framework for Dementia Research Data
Miguel Germán Borda,
Daniel Ferreira,
Per Selnes,
Diego Alejandro Tovar-Rios,
Alberto Jaramillo-Jiménez,
Bjørn-Eivind Kirsebom
m.fl.:
Timed Up and Go in People with Subjective Cognitive Decline Is Associated with Faster Cognitive Deterioration and Cortical Thickness
Jacob Espenes,
Ingvild Vøllo Eliassen,
Fredrik Öhman,
Erik Hessen,
Knut K Waterloo,
Marie Eckerström
m.fl.:
Regression‐based normative data for the Rey Auditory Verbal Learning Test in Norwegian and Swedish adults aged 49–79 and comparison with published norms
Ingvild Vøllo Eliassen,
Bjørn-Eivind Kirsebom,
Tormod Fladby,
Knut Waterloo,
Sigrid Botne Sando,
Mathilde Suhr Hemminghyth
m.fl.:
Regression-Based Cognitive Change Norms Applied in Biochemically Defined Predementia Alzheimer’s Disease
Bjørn-Eivind Kirsebom,
Grit Richter,
Kaja Nordengen,
Dag Aarsland,
Geir Bråthen,
Betty M Tijms
m.fl.:
Stable cerebrospinal fluid neurogranin and β-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer's disease patients
Ingrid Myrvoll Lorentzen,
Johan Jacob Espenes,
Erik Hessen,
Knut Waterloo,
Geir Bråthen,
Santiago Timón
m.fl.:
Regression-based norms for the FAS phonemic fluency test for ages 40–84 based on a Norwegian sample
Nikias Ioannis Siafarikas,
Bjørn-Eivind Kirsebom,
Deepak P Srivastava,
Cecilia Magdalena Eriksson,
Eirik Auning,
Erik Hessen
m.fl.:
Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression
Johan Jacob Espenes,
Erik Hessen,
Ingvild Vøllo Eliassen,
Knut Waterloo,
Marie Eckerström,
Sigrid Botne Sando
m.fl.:
Demographically adjusted trail making test norms in a Scandinavian sample from 41 to 84 years
Anne Katrine Bergland,
Petroula Proitsi,
Bjørn-Eivind Kirsebom,
Hogne Sønnesyn,
Abdul Hye,
Alf Inge Larsen
m.fl.:
Exploration of plasma lipids in mild cognitive impairment due to Alzheimer's disease
Journal of Alzheimer's Disease 2020 DOI
Ragna Espenes,
Bjørn-Eivind Kirsebom,
Cecilia Magdalena Eriksson,
Knut K Waterloo,
Erik Hessen,
Stein Harald Johnsen
m.fl.:
Amyloid plaques and symptoms of depression links to medical help-seeking due to subjective cognitive decline
Ingvild Vøllo Eliassen,
Tormod Fladby,
Bjørn-Eivind Kirsebom,
Knut Waterloo,
Marie Eckerström,
Anders Wallin
m.fl.:
Predictive and diagnostic utility of brief neuropsychological assessment in detecting Alzheimer's pathology and progression to dementia
Kaja Nordengen,
Bjørn-Eivind Kirsebom,
Kristi Henjum,
Per Selnes,
Berglind Gisladottir,
Marianne Wettergreen
m.fl.:
Glial activation and inflammation along the Alzheimer's disease continuum
Bjørn-Eivind Kirsebom,
Ragna Espenes,
Erik Hessen,
Knut Waterloo,
Stein Harald Johnsen,
Elisabeth Gundersen
m.fl.:
Demographically adjusted CERAD wordlist test norms in a Norwegian sample from 40 to 80 years
Erik Hessen,
Bjørn-Eivind Kirsebom,
Cecilia Magdalena Eriksson,
Carl Fredrik Andestad Eliassen,
Arne Nakling,
Geir Bråthen
m.fl.:
In Brief Neuropsychological Assessment, Amnestic Mild Cognitive Impairment (MCI) Is associated with Cerebrospinal Fluid Biomarkers for Cognitive Decline in Contrast to the Prevailing NIA-AA MCI Criterion
Bjørn-Eivind Kirsebom,
Kaja Nordengen,
Per Selnes,
Knut Waterloo,
Silje Bøen Torsetnes,
Berglind Gisladottir
m.fl.:
Cerebrospinal fluid neurogranin/β-site APP-cleaving enzyme 1 predicts cognitive decline in preclinical Alzheimer's disease
Bjørn-Eivind Seljelid Bordewic Kirsebom,
Ragna Espenes,
Knut Waterloo,
Erik Hessen,
Stein Harald Johnsen,
Geir Bråthen
m.fl.:
Screening for Alzheimer’s Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients
Tormod Fladby,
Lene Pålhaugen,
Per Selnes,
Knut Waterloo,
Geir Bråthen,
Erik Hessen
m.fl.:
Detecting at-risk Alzheimer's disease cases
Journal of Alzheimer's Disease 29. august 2017 DOI
Mathilde Suhr Hemminghyth,
Monica Haraldseid Breitve,
Berglind Gisladottir,
Gøril Rolfseng Grøntvedt,
Arne Exner Nakling,
Tormod Fladby
m.fl.:
Cerebrospinal fluid neurofilament light chain mediates age-related decline in learning and memory in healthy adults
2023
Nikias Ioannis Siafarikas,
Bjørn-Eivind Kirsebom,
Deepak P. Srivastava,
Cecilia Magdalena Eriksson,
Eirik Auning,
Erik Hessen
m.fl.:
Author Correction: Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression (Scientific Reports, (2021), 11, 1, (20375), 10.1038/s41598-021-99794-9)
Scientific Reports 2022 DOI
Bjørn-Eivind Kirsebom
:
Hva vet vi om Alzheimers sykdom i dag, og finnes det en kur?
Nordlys 21. september 2020 DATA
Johan Jacob Espenes,
Ingvild Vøllo Eliassen,
Tormod Fladby,
Marie Eckerström,
Wallin Anders,
Knut Waterloo
m.fl.:
Demographically adjusted test norms for the Rey Auditory Verbal Learning Test in Norwegian and Swedish adults
from 41 to 79 years
2020
Ragna Espenes,
Bjørn-Eivind Kirsebom,
Cecilia Magdalena Eriksson,
Knut Waterloo,
Stein Harald Johnsen,
Erik Hessen
m.fl.:
Medical help-seeking in Subjective Cognitive Decline associated with lower CSF Aβ1-42 and reduced memory performance
2019
Bjørn-Eivind Kirsebom
:
Vil avdekke Alzheimers sykdom så tidlig som mulig
05. juni 2019
Ingvild Vøllo Eliassen,
Bjørn-Eivind Kirsebom,
Erik Hessen,
Per Selnes,
Knut Waterloo,
Tormod Fladby
:
Distractor List Errors from Verbal Learning Test May Reveal Deficient Temporal Memory Encoding in Predementia Alzheimer’s Disease
2019
Bjørn-Eivind Kirsebom
:
Tromsø-forskere jobber intenst med å løse alzheimer-gåten
28. desember 2019
Bjørn-Eivind Kirsebom
:
Frykter fordobling av demenstilfeller innen 2050: Tromsø-forskere undersøker om blåbær kan være kuren
14. august 2019 DATA
Johan Jacob Espenes,
Bjørn-Eivind Kirsebom,
Ingvild Eliassen Vøllo,
Ragna Espenes,
Knut Waterloo,
Erik Hessen
m.fl.:
Demographically adjusted norms for basic and derived measures on the Trail Making Test A & B based on a Norwegian sample age 40 – 84 years.
2019
Bjørn-Eivind Kirsebom,
Tine Viktoria Buberg
:
Forsker på demens: – Antioksidanter fra blåbær kan bidra til å bremse demens
07. august 2019
Grit Richter,
Bjørn-Eivind Kirsebom,
Per Selnes,
Kaja Nordengen,
Knut Waterloo,
Berglind Gisladottir
m.fl.:
An amyloid-coupled pre-dementia increased CSF neurogranin/BACE1 ratio may reflect early synapse affection in APOE-ɛ4 homozygotes
2019
Bjørn-Eivind Kirsebom,
Per Selnes,
Grit Richter,
Berglind Gisladottir,
Marianne Wettergreen,
Silje Bøen Torsetnes
m.fl.:
Cerebrospinal fluid Neurogranin/BACE1 ratio differentiate normal controls, pre-dementia Alzheimer’s and Parkinson’s disease cases.
2019
Grit Richter,
Bjørn-Eivind Kirsebom,
Per Selnes,
Kaja Nordengen,
Knut Waterloo,
Berglind Gisladottir
m.fl.:
Early increase in CSF neurogranin/BACE1 ratio in predementia APOE-ɛ4 homozygote cases with amyloid pathology
2019
Bjørn-Eivind Kirsebom,
Kaja Nordengen,
Per Selnes,
Knut Waterloo,
Britta Brix,
Eugeen Vanmechelen
m.fl.:
INCREASED CSF NEUROGRANIN/BACE1 RATIO IN AMYLOID POSITIVE SUBJECTS WITH SUBJECTIVE COGNITIVE DECLINE
2018
Bjørn-Eivind Kirsebom,
Ragna Espenes,
Knut Waterloo,
Stein Harald Johnsen,
Tormod Fladby
:
Screening for Alzheimer's Disease: Cognitive Impairent in Self-Referred and Memory Clinic-Referred Patients
2017
De 50 siste resultatene fra Cristin vises på siden. Se alle arbeider i Cristin her →
Forskningsinteresser
Klinisk nevropsykologi og regresjonsbaserte normer. Preklinisk og prodromal Alzheimers sykdom.
